Amplify Weight Loss Drug & Treatment ETF

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THNR and other ETFs, options, and stocks.

About THNR

THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses.

Index-Tracked

VettaFi Weight Loss Drug & Treat TR USD

Index-TrackedVettaFi Weight Loss Drug & Treat TR USD

What's in this fund

Sectors

As of November 5, 2025

Healthcare100.00%

Top 10 Holdings (71.38% of total assets)

As of November 5, 2025

NameSymbol% Assets

Eli LillyLLY15.00%

Novo NordiskNVO10.92%

RegeneronREGN7.41%

AmgenAMGN7.38%

Chugai Pharmaceutical Co Ltd4519 (XTKS)6.51%

Roche Holding AGROG (XSWX)4.75%

THNR Key Statistics

AUM

2.58M

AUM2.58M

Price-Earnings ratio

19.63

Price-Earnings ratio19.63

30-Day yield

1.46

30-Day yield1.46

Average volume

1.30K

Average volume1.30K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$25.08

52 Week high$25.08

52 Week low

$18.56

52 Week low$18.56

Expense ratio

0.59

Expense ratio0.59

View Prospectus and Reports

Stock Snapshot

With a market cap of 2.58M, Amplify Weight Loss Drug & Treatment ETF(THNR) trades at $23.50. The stock has a price-to-earnings ratio of 19.63 and currently yields dividends of 2.0%.

On 2025-11-07, Amplify Weight Loss Drug & Treatment ETF(THNR) stock opened at —, reached a high of —, and a low of —.

Amplify Weight Loss Drug & Treatment ETF(THNR) shares are trading with a volume of 0, against a daily average of 1.3K.

During the past year, Amplify Weight Loss Drug & Treatment ETF(THNR) stock moved between $18.56 at its lowest and $25.08 at its peak.